                               SEQUENCE LISTING

<110> DIADEXUS, INC.
 
<120> LONG SHELF-LIFE KITS AND METHODS FOR STANDARDIZING, 
      VERIFYING, CALIBRATING OR RECALIBRATING DETECTION OF 
      LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2

<130> 12248-702.600

<140> NOT YET ASSIGNED
<141> 2014-09-24

<150> 61/881,881
<151> 2013-09-24

<150> 14/279,106
<151> 2014-05-14

<150> 14/279,148
<151> 2014-05-14

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 420
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Phe Asp Trp Gln Tyr Ile Asn Pro Val Ala His Met Lys Ser Ser Ala 
1               5                   10                  15      


Trp Val Asn Lys Ile Gln Val Leu Met Ala Ala Ala Ser Phe Gly Gln 
            20                  25                  30          


Thr Lys Ile Pro Arg Gly Asn Gly Pro Tyr Ser Val Gly Cys Thr Asp 
        35                  40                  45              


Leu Met Phe Asp His Thr Asn Lys Gly Thr Phe Leu Arg Leu Tyr Tyr 
    50                  55                  60                  


Pro Ser Gln Asp Asn Asp Arg Leu Asp Thr Leu Trp Ile Pro Asn Lys 
65                  70                  75                  80  


Glu Tyr Phe Trp Gly Leu Ser Lys Phe Leu Gly Thr His Trp Leu Met 
                85                  90                  95      


Gly Asn Ile Leu Arg Leu Leu Phe Gly Ser Met Thr Thr Pro Ala Asn 
            100                 105                 110         


Trp Asn Ser Pro Leu Arg Pro Gly Glu Lys Tyr Pro Leu Val Val Phe 
        115                 120                 125             


Ser His Gly Leu Gly Ala Phe Arg Thr Leu Tyr Ser Ala Ile Gly Ile 
    130                 135                 140                 


Asp Leu Ala Ser His Gly Phe Ile Val Ala Ala Val Glu His Arg Asp 
145                 150                 155                 160 


Arg Ser Ala Ser Ala Thr Tyr Tyr Phe Lys Asp Gln Ser Ala Ala Glu 
                165                 170                 175     


Ile Gly Asp Lys Ser Trp Leu Tyr Leu Arg Thr Leu Lys Gln Glu Glu 
            180                 185                 190         


Glu Thr His Ile Arg Asn Glu Gln Val Arg Gln Arg Ala Lys Glu Cys 
        195                 200                 205             


Ser Gln Ala Leu Ser Leu Ile Leu Asp Ile Asp His Gly Lys Pro Val 
    210                 215                 220                 


Lys Asn Ala Leu Asp Leu Lys Phe Asp Met Glu Gln Leu Lys Asp Ser 
225                 230                 235                 240 


Ile Asp Arg Glu Lys Ile Ala Val Ile Gly His Ser Phe Gly Gly Ala 
                245                 250                 255     


Thr Val Ile Gln Thr Leu Ser Glu Asp Gln Arg Phe Arg Cys Gly Ile 
            260                 265                 270         


Ala Leu Asp Ala Trp Met Phe Pro Leu Gly Asp Glu Val Tyr Ser Arg 
        275                 280                 285             


Ile Pro Gln Pro Leu Phe Phe Ile Asn Ser Glu Tyr Phe Gln Tyr Pro 
    290                 295                 300                 


Ala Asn Ile Ile Lys Met Lys Lys Cys Tyr Ser Pro Asp Lys Glu Arg 
305                 310                 315                 320 


Lys Met Ile Thr Ile Arg Gly Ser Val His Gln Asn Phe Ala Asp Phe 
                325                 330                 335     


Thr Phe Ala Thr Gly Lys Ile Ile Gly His Met Leu Lys Leu Lys Gly 
            340                 345                 350         


Asp Ile Asp Ser Asn Val Ala Ile Asp Leu Ser Asn Lys Ala Ser Leu 
        355                 360                 365             


Ala Phe Leu Gln Lys His Leu Gly Leu His Lys Asp Phe Asp Gln Trp 
    370                 375                 380                 


Asp Cys Leu Ile Glu Gly Asp Asp Glu Asn Leu Ile Pro Gly Thr Asn 
385                 390                 395                 400 


Ile Asn Thr Thr Asn Gln His Ile Met Leu Gln Asn Ser Ser Gly Ile 
                405                 410                 415     


Glu Lys Tyr Asn 
            420 


<210> 2
<211> 438
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Met Gly His His His His His His Ser Gly Ser Glu Phe Glu Leu Arg 
1               5                   10                  15      


Arg Gln Phe Asp Trp Gln Tyr Ile Asn Pro Val Ala His Met Lys Ser 
            20                  25                  30          


Ser Ala Trp Val Asn Lys Ile Gln Val Leu Met Ala Ala Ala Ser Phe 
        35                  40                  45              


Gly Gln Thr Lys Ile Pro Arg Gly Asn Gly Pro Tyr Ser Val Gly Cys 
    50                  55                  60                  


Thr Asp Leu Met Phe Asp His Thr Asn Lys Gly Thr Phe Leu Arg Leu 
65                  70                  75                  80  


Tyr Tyr Pro Ser Gln Asp Asn Asp Arg Leu Asp Thr Leu Trp Ile Pro 
                85                  90                  95      


Asn Lys Glu Tyr Phe Trp Gly Leu Ser Lys Phe Leu Gly Thr His Trp 
            100                 105                 110         


Leu Met Gly Asn Ile Leu Arg Leu Leu Phe Gly Ser Met Thr Thr Pro 
        115                 120                 125             


Ala Asn Trp Asn Ser Pro Leu Arg Pro Gly Glu Lys Tyr Pro Leu Val 
    130                 135                 140                 


Val Phe Ser His Gly Leu Gly Ala Phe Arg Thr Leu Tyr Ser Ala Ile 
145                 150                 155                 160 


Gly Ile Asp Leu Ala Ser His Gly Phe Ile Val Ala Ala Val Glu His 
                165                 170                 175     


Arg Asp Arg Ser Ala Ser Ala Thr Tyr Tyr Phe Lys Asp Gln Ser Ala 
            180                 185                 190         


Ala Glu Ile Gly Asp Lys Ser Trp Leu Tyr Leu Arg Thr Leu Lys Gln 
        195                 200                 205             


Glu Glu Glu Thr His Ile Arg Asn Glu Gln Val Arg Gln Arg Ala Lys 
    210                 215                 220                 


Glu Cys Ser Gln Ala Leu Ser Leu Ile Leu Asp Ile Asp His Gly Lys 
225                 230                 235                 240 


Pro Val Lys Asn Ala Leu Asp Leu Lys Phe Asp Met Glu Gln Leu Lys 
                245                 250                 255     


Asp Ser Ile Asp Arg Glu Lys Ile Ala Val Ile Gly His Ser Phe Gly 
            260                 265                 270         


Gly Ala Thr Val Ile Gln Thr Leu Ser Glu Asp Gln Arg Phe Arg Cys 
        275                 280                 285             


Gly Ile Ala Leu Asp Ala Trp Met Phe Pro Leu Gly Asp Glu Val Tyr 
    290                 295                 300                 


Ser Arg Ile Pro Gln Pro Leu Phe Phe Ile Asn Ser Glu Tyr Phe Gln 
305                 310                 315                 320 


Tyr Pro Ala Asn Ile Ile Lys Met Lys Lys Cys Tyr Ser Pro Asp Lys 
                325                 330                 335     


Glu Arg Lys Met Ile Thr Ile Arg Gly Ser Val His Gln Asn Phe Ala 
            340                 345                 350         


Asp Phe Thr Phe Ala Thr Gly Lys Ile Ile Gly His Met Leu Lys Leu 
        355                 360                 365             


Lys Gly Asp Ile Asp Ser Asn Val Ala Ile Asp Leu Ser Asn Lys Ala 
    370                 375                 380                 


Ser Leu Ala Phe Leu Gln Lys His Leu Gly Leu His Lys Asp Phe Asp 
385                 390                 395                 400 


Gln Trp Asp Cys Leu Ile Glu Gly Asp Asp Glu Asn Leu Ile Pro Gly 
                405                 410                 415     


Thr Asn Ile Asn Thr Thr Asn Gln His Ile Met Leu Gln Asn Ser Ser 
            420                 425                 430         


Gly Ile Glu Lys Tyr Asn 
        435             


<210> 3
<211> 437
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Met Gly His His His His His His Ser Gly Ser Glu Phe Glu Leu Arg 
1               5                   10                  15      


Arg Gln Phe His Trp Gln Asp Thr Ser Ser Phe Asp Phe Arg Pro Ser 
            20                  25                  30          


Val Met Phe His Lys Leu Gln Ser Val Met Ser Ala Ala Gly Ser Gly 
        35                  40                  45              


His Ser Lys Ile Pro Lys Gly Asn Gly Ser Tyr Pro Val Gly Cys Thr 
    50                  55                  60                  


Asp Leu Met Phe Gly Tyr Gly Asn Glu Ser Val Phe Val Arg Leu Tyr 
65                  70                  75                  80  


Tyr Pro Ala Gln Asp Gln Gly Arg Leu Asp Thr Val Trp Ile Pro Asn 
                85                  90                  95      


Lys Glu Tyr Phe Leu Gly Leu Ser Ile Phe Leu Gly Thr Pro Ser Ile 
            100                 105                 110         


Val Gly Asn Ile Leu His Leu Leu Tyr Gly Ser Leu Thr Thr Pro Ala 
        115                 120                 125             


Ser Trp Asn Ser Pro Leu Arg Thr Gly Glu Lys Tyr Pro Leu Ile Val 
    130                 135                 140                 


Phe Ser His Gly Leu Gly Ala Phe Arg Thr Ile Tyr Ser Ala Ile Gly 
145                 150                 155                 160 


Ile Gly Leu Ala Ser Asn Gly Phe Ile Val Ala Thr Val Glu His Arg 
                165                 170                 175     


Asp Arg Ser Ala Ser Ala Thr Tyr Phe Phe Glu Asp Gln Val Ala Ala 
            180                 185                 190         


Lys Val Glu Asn Arg Ser Trp Leu Tyr Leu Arg Lys Val Lys Gln Glu 
        195                 200                 205             


Glu Ser Glu Ser Val Arg Lys Glu Gln Val Gln Gln Arg Ala Ile Glu 
    210                 215                 220                 


Cys Ser Arg Ala Leu Ser Ala Ile Leu Asp Ile Glu His Gly Asp Pro 
225                 230                 235                 240 


Lys Glu Asn Val Leu Gly Ser Ala Phe Asp Met Lys Gln Leu Lys Asp 
                245                 250                 255     


Ala Ile Asp Glu Thr Lys Ile Ala Leu Met Gly His Ser Phe Gly Gly 
            260                 265                 270         


Ala Thr Val Leu Gln Ala Leu Ser Glu Asp Gln Arg Phe Arg Cys Gly 
        275                 280                 285             


Val Ala Leu Asp Pro Trp Met Tyr Pro Val Asn Glu Glu Leu Tyr Ser 
    290                 295                 300                 


Arg Thr Leu Gln Pro Leu Leu Phe Ile Asn Ser Ala Lys Phe Gln Thr 
305                 310                 315                 320 


Pro Lys Asp Ile Ala Lys Met Lys Lys Phe Tyr Gln Pro Asp Lys Glu 
                325                 330                 335     


Arg Lys Met Ile Thr Ile Lys Gly Ser Val His Gln Asn Phe Asp Asp 
            340                 345                 350         


Phe Thr Phe Val Thr Gly Lys Ile Ile Gly Asn Lys Leu Thr Leu Lys 
        355                 360                 365             


Gly Glu Ile Asp Ser Arg Val Ala Ile Asp Leu Thr Asn Lys Ala Ser 
    370                 375                 380                 


Met Ala Phe Leu Gln Lys His Leu Gly Leu Gln Lys Asp Phe Asp Gln 
385                 390                 395                 400 


Trp Asp Pro Leu Val Glu Gly Asp Asp Glu Asn Leu Ile Pro Gly Ser 
                405                 410                 415     


Pro Phe Asp Ala Val Thr Gln Val Pro Ala Gln Gln His Ser Pro Gly 
            420                 425                 430         


Ser Gln Thr Gln Asn 
        435         


<210> 4
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Val Asp His His His His His His 
1               5               


